Cancer Center is undertaking a Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer
Memorial Sloan Kettering Cancer Center is commencing recruitment for the clinical trial of a Shortened Radiation Therapy Schedule in People With Breast Cancer.
The purpose of this study is to see whether providing radiation on a shortened (compressed) schedule of 5 days in a row is a safe and effective approach to prevent cancer from coming back in people who have had a mastectomy.
The conditions are Invasive Breast Cancer, Post-mastectomy.
A new clinical trial is recruiting patients in the following locations: Memorial Sloan Kettering Cancer Center, New York, New York, United States, 10065.
The trial officially began on the November 24, 2020 and is planned to complete on November 2023.
Among the criteria that allow participation, the following are indicated:
- Female or male patients with invasive breast cancer who have had mastectomy and have a chest wall reconstruction in progress or completed.
- Age ≥ 30 years.
- Final AJCC Stage IIa - IIIa (pathologic stage T0N1a-2a, T1N1a-2a, T2N1a-2a, T3N0-2a, all M0 status). Pathological stage for all patients not receiving neoadjuvant chemotherapy. Higher of the clinical or pathological T and N stage, if receiving neoadjuvant chemotherapy. Patients with pathological T1-2,N0 at the time of mastectomy are only eligible if biopsy-proven clinically N1 or N2 disease is documented prior to induction chemotherapy.
- Histologically negative tumor margin.
- ECOG Performance Status of 0 or 1.
The link to the complete study profile: https://ichgcp.net/clinical-trials-registry/NCT04648904
